Cochrane Abstracts
De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV‐positive oropharyngeal carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"De‐intensified Adjuvant (chemo)radiotherapy Versus Standard Adjuvant Chemoradiotherapy Post Transoral Minimally Invasive Surgery for Resectable HPV‐positive Oropharyngeal Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439803/all/De‐intensified_adjuvant__chemo_radiotherapy_versus_standard_adjuvant_chemoradiotherapy_post_transoral_minimally_invasive_surgery_for_resectable_HPV‐positive_oropharyngeal_carcinoma.
De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV‐positive oropharyngeal carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439803/all/De‐intensified_adjuvant__chemo_radiotherapy_versus_standard_adjuvant_chemoradiotherapy_post_transoral_minimally_invasive_surgery_for_resectable_HPV‐positive_oropharyngeal_carcinoma. Accessed March 26, 2025.
De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV‐positive oropharyngeal carcinoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439803/all/De‐intensified_adjuvant__chemo_radiotherapy_versus_standard_adjuvant_chemoradiotherapy_post_transoral_minimally_invasive_surgery_for_resectable_HPV‐positive_oropharyngeal_carcinoma
De‐intensified Adjuvant (chemo)radiotherapy Versus Standard Adjuvant Chemoradiotherapy Post Transoral Minimally Invasive Surgery for Resectable HPV‐positive Oropharyngeal Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439803/all/De‐intensified_adjuvant__chemo_radiotherapy_versus_standard_adjuvant_chemoradiotherapy_post_transoral_minimally_invasive_surgery_for_resectable_HPV‐positive_oropharyngeal_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV‐positive oropharyngeal carcinoma
ID - 439803
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439803/all/De‐intensified_adjuvant__chemo_radiotherapy_versus_standard_adjuvant_chemoradiotherapy_post_transoral_minimally_invasive_surgery_for_resectable_HPV‐positive_oropharyngeal_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
